ROTHBLATT MARTINE A (Chairperson & CEO) sold 2.8% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $4.63M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+8.91K
Price / share
$135.42
Trade value
$1.21M
% of position
Common Stock
Shares
+590.00
Price / share
$117.76
Trade value
$69.48K
% of position
Common Stock
Shares
−200.00
Price / share
$479.07
Trade value
$95.81K
% of position
Common Stock
Shares
−440.00
Price / share
$480.53
Trade value
$211.43K
% of position
Common Stock
Shares
−600.00
Price / share
$481.47
Trade value
$288.88K
% of position
Common Stock
Shares
−400.00
Price / share
$482.35
Trade value
$192.94K
% of position
Common Stock
Shares
−80.00
Price / share
$483.69
Trade value
$38.70K
% of position
Common Stock
Shares
−240.00
Price / share
$485.16
Trade value
$116.44K
% of position
Common Stock
Shares
−411.00
Price / share
$486.72
Trade value
$200.04K
% of position
Common Stock
Shares
−1.43K
Price / share
$487.87
Trade value
$697.16K
% of position
Common Stock
Shares
−1.60K
Price / share
$488.68
Trade value
$783.85K
% of position
Common Stock
Shares
−3.11K
Price / share
$489.62
Trade value
$1.52M
% of position
Common Stock
Shares
−940.00
Price / share
$490.50
Trade value
$461.07K
% of position
Common Stock
Shares
−42.00
Price / share
$491.25
Trade value
$20.63K
% of position
Net shares
+0.00
Net value
-$3.36M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/3/2026 | M · Option Exercise | +8.91K | $135.42 | $1.21M | 2.7% | 324.44K | 333.35K |
| Common Stock Indirect | 9/3/2026 | M · Option Exercise | +590.00 | $117.76 | $69.48K | 0.2% | 333.35K | 333.94K |
| Common Stock Indirect | 9/3/2026 | S · Sale | −200.00 | $479.07 | $95.81K | 0.1% | 333.94K | 333.74K |
| Common Stock Indirect | 9/3/2026 | S · Sale | −440.00 | $480.53 | $211.43K | 0.1% | 333.74K | 333.30K |
| Common Stock Indirect | 9/3/2026 | S · Sale | −600.00 | $481.47 | $288.88K | 0.2% | 333.30K | 332.70K |
| Common Stock Indirect | 9/3/2026 | S · Sale | −400.00 | $482.35 | $192.94K | 0.1% | 332.70K | 332.30K |
| Common Stock Indirect | 9/3/2026 | S · Sale | −80.00 | $483.69 | $38.70K | 0.0% | 332.30K | 332.22K |
| Common Stock Indirect | 9/3/2026 | S · Sale | −240.00 | $485.16 | $116.44K | 0.1% | 332.22K | 331.98K |
| Common Stock Indirect | 9/3/2026 | S · Sale | −411.00 | $486.72 | $200.04K | 0.1% | 331.98K | 331.57K |
| Common Stock Indirect | 9/3/2026 | S · Sale | −1.43K | $487.87 | $697.16K | 0.4% | 331.57K | 330.14K |
| Common Stock Indirect | 9/3/2026 | S · Sale | −1.60K | $488.68 | $783.85K | 0.5% | 330.14K | 328.54K |
| Common Stock Indirect | 9/3/2026 | S · Sale | −3.11K | $489.62 | $1.52M | 0.9% | 328.54K | 325.43K |
| Common Stock Indirect | 9/3/2026 | S · Sale | −940.00 | $490.50 | $461.07K | 0.3% | 325.43K | 324.49K |
| Common Stock Indirect | 9/3/2026 | S · Sale | −42.00 | $491.25 | $20.63K | 0.0% | 324.49K | 324.44K |
| Total | +0.00 | -$3.36M | ||||||
Stock Option
Common Stock
8.91K shares
Shares
−8.91K
Strike price
135.42
Held after
0.00
Exercisable
—
Stock Option
Common Stock
590.00 shares
Shares
−590.00
Strike price
117.76
Held after
499.41K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Indirect | Common Stock8.91K shares | 9/3/2026 | M · Option Exercise | −8.91K | 135.42 | — | 0.00 |
| Stock Option Indirect | Common Stock590.00 shares | 9/3/2026 | M · Option Exercise | −590.00 | 117.76 | — | 499.41K |
Common Stock
DirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40.51K | Direct |
| Common Stock | 45.60K | Indirect |
| Common Stock | 166.00 | Indirect |
| Common Stock | 8.90K | Indirect |
| Common Stock | 249.11K | Indirect |
| Total | 344.29K | 40.51K direct·303.77K indirect |